Life science focus Genoa Ventures specializes in early-stage life science tech at the intersection of biology and technology, presenting sales opportunities with startups pursuing cross-disciplinary innovations in genomics, optics, microfluidics, and data analytics.

Category-defying Target opportunities that don’t fit traditional VC patterns, such as market-making or deeply tech-centric bio ventures, where Genoa’s hands-on scientific and operational support can unlock capital-efficient growth.

Strategic hardware & software Leverage Genoa’s tech stack and penchant for multi-disciplinary platforms by offering tools, platforms, or services that enhance research, data processing and productization in life sciences.

Recent wins Recent investments include Epitel in AI-driven brain health tech and BrightSpec in MR spectroscopy tools, signaling readiness to back frontier tech; align outreach with their co-led and strategic investor dynamics.

Fundraising agility Genoa has demonstrated founder-friendly recognition and scale via leadership hires and board-level involvement, suggesting openness to co-investments, strategic partnerships, and accelerator-type collaborations to accelerate portfolio growth.